Show simple item record

dc.contributor.authorBalieva, Flora
dc.contributor.authorFinlay, Andrew Y.
dc.contributor.authorKupfer, Joerg
dc.contributor.authorTomas-Aragones, Lucia
dc.contributor.authorLien, Lars
dc.contributor.authorGieler, Uwe
dc.contributor.authorPoot, Francoise
dc.contributor.authorJemec, Gregor B.E.
dc.contributor.authorMisery, Laurent
dc.contributor.authorKemeny, L
dc.contributor.authorSampogna, Francesca
dc.contributor.authorVan Middendorp, Henriët
dc.contributor.authorHalvorsen, Jon Anders
dc.contributor.authorTernowitz, T
dc.contributor.authorSzepietowski, Jacek C.
dc.contributor.authorPotekaev, N
dc.contributor.authorMarron, SE
dc.contributor.authorAltunay, Ilknur K.
dc.contributor.authorSalek, Mir-Saeed Shayegan
dc.contributor.authorDalgard, Florence
dc.date.accessioned2018-11-21T12:38:59Z
dc.date.available2018-11-21T12:38:59Z
dc.date.issued2018-06-08
dc.identifier.citationBalieva , F , Finlay , A Y , Kupfer , J , Tomas-Aragones , L , Lien , L , Gieler , U , Poot , F , Jemec , G B E , Misery , L , Kemeny , L , Sampogna , F , Van Middendorp , H , Halvorsen , J A , Ternowitz , T , Szepietowski , J C , Potekaev , N , Marron , SE , Altunay , I K , Salek , M-S S & Dalgard , F 2018 , ' The Role of Therapy in Impairing Quality of Life in Dermatological Patients: A Multinational Study ' , Acta Dermato-Venereologica , vol. 98 , no. 6 , pp. 563-569 . https://doi.org/10.2340/00015555-2918
dc.identifier.issn0001-5555
dc.identifier.otherPURE: 15428517
dc.identifier.otherPURE UUID: 0ded68b3-a217-4d13-a479-44b82ba511ad
dc.identifier.otherScopus: 85048506517
dc.identifier.urihttp://hdl.handle.net/2299/20813
dc.description.abstractSkin disease and its therapy affect health-related quality of life (HRQoL). The aim of this study was to measure the burden caused by dermatological therapy in 3,846 patients from 13 European countries. Adult outpatients completed questionnaires, including the Dermatology Life Quality Index (DLQI), which has a therapy impact question. Therapy issues were reported by a majority of patients with atopic dermatitis (63.4%), psoriasis (60.7%), prurigo (54.4%), hidradenitis suppurativa (54.3%) and blistering conditions (53%). The largest reduction in HRQoL attributable to therapy, as a percentage of total DLQI, adjusted for confounders, was seen in blistering conditions (10.7%), allergic/drug reactions (10.2%), psoriasis (9.9%), vasculitis/immunological ulcers (8.8%), atopic dermatitis (8.7%), and venous leg ulcers (8.5%). In skin cancer, although it had less impact on HRQoL, the reduction due to therapy was 6.8%. Treatment for skin disease contributes considerably to reducing HRQoL: the burden of dermatological treatment should be considered when planning therapy and designing new dermatological therapies.en
dc.format.extent7
dc.language.isoeng
dc.relation.ispartofActa Dermato-Venereologica
dc.subjectBurden of skin disease
dc.subjectDLQI
dc.subjectDermatological therapy
dc.subjectHRQoL
dc.subjectQuality of life
dc.subjectTherapy burden
dc.subjectDermatology
dc.titleThe Role of Therapy in Impairing Quality of Life in Dermatological Patients: A Multinational Studyen
dc.contributor.institutionDepartment of Pharmacy, Pharmacology and Postgraduate Medicine
dc.contributor.institutionPublic Health and Patient Safety Unit
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionDepartment of Clinical and Pharmaceutical Sciences
dc.description.statusPeer reviewed
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85048506517&partnerID=8YFLogxK
rioxxterms.versionVoR
rioxxterms.versionofrecordhttps://doi.org/10.2340/00015555-2918
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record